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Abstract
Introduction. Infection with the Rasamsonia argillacea species complex represents an emerging problem in human and
veterinary medicine with systemic mycoses presenting with significant clinical complications and being a cause of death.
Case presentation. In this report, a case of systemic Rasamsonia piperina infection discovered in a 3-year-old male neutered,
German shepherd cross dog is described together with the clinical presentation, the course of the disease and diagnosis.
This report describes the first case of veterinary mycosis due to R. piperina in Europe and the first case in humans or
animals in the UK.
Conclusion. Although seemingly rare, R. argillacea species complex infection should be a differential diagnosis for dogs,
especially German shepherds with the described presenting signs, and radiographic and ultrasonographic findings.
INTRODUCTION
Rasamsonia argillacea species complex infections are an
emerging problem in human medicine. In the absence of
molecular diagnostics, morphological similarity to other
fungi may cause misidentification of Rasamsonia species
and thus their role as pathogens may be underappreciated.
Veterinary Rasamsonia species infections have so far been
limited to two previous cases and here we report a case of
systemic Rasamsonia piperina infection in a 3-year-old,
male neutered, German shepherd cross dog. In addition to
being the first case of veterinary R. piperina mycosis in
Europe and the first R. piperina case in humans or animals
in the UK, this is also the first veterinary case of systemic
mycosis due to R. piperina in a dog with macroscopic
pulmonary, pleural, splenic, hepatic and lymphoid
involvement.
CASE REPORT
A 3-year-old, male neutered, German shepherd cross dog
presented with a 4week history of intermittent left hind
limb, non-weight-bearing lameness. On physical examina-
tion the patient was resenting extension of hip joints and
pain reaction was elicited on palpation of the left humerus.
Initial treatment with meloxicam and tramadol did not
resolve the clinical signs and the dog presented again 3
months later. On the second assessment the left hind limb
lameness persisted and pain was also found on palpation of
the left humeral, and both femoral diaphyses. Radiographs
revealed a moderate, generalized and patchy increase in
radiopacity in the medulla of the left femoral diaphysis.
Smooth, continuous periosteal new bone formation
extended along the medial and caudal cortex of the proxi-
mal third of the diaphysis. A diagnosis of left femoral pan-
osteitis was made and the patient was discharged with
exercise restriction and analgesia. The lameness failed to
improve and the dog presented again a few days later, this
time with shifting lameness involving left front and hind
limbs and pyrexia. Recent lethargy, hyporexia, vomiting and
restlessness were also reported.
An investigation of pyrexia of unknown origin was initiated.
Blood analysis revealed monocytosis [12.2109 l–1, refer-
ence interval (RI) 0–1.5], hypoalbuminaemia (21.5 g l–1, RI
26–35) and hyperglobulinaemia (42 g l–1, RI 18–37). Radi-
ography of the right femur showed an aggressive proximal
diaphyseal lesion, which had progressed compared to previ-
ous images, with secondary disuse muscle atrophy (Fig. 1).
Differential diagnoses included fungal or bacterial osteomy-
elitis. An adjacent soft tissue neoplasm was considered less
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likely. Thoracic radiographs revealed partial right middle
lung lobe consolidation with lobar pneumonia and small- to
moderate-volume right-sided pleural effusion.
On abdominal ultrasound there was marked mass effect in
the cranial abdomen associated with marked generalized
lymphadenopathy, steatitis and minimal peritoneal effusion.
The spleen was enlarged with irregular margins, and moder-
ately heterogeneous. Thoracentesis was performed and fine
needle aspirates were taken from the spleen, lymph nodes
and mass in the cranial abdomen.
Cranial abdominal mass and lymph node fine needle aspi-
rates were consistent with marked pyogranulomatous
inflammation with multinucleated giant cells and intra-
lesional fungal hyphae. Hyphae were 2–3 µm in width, and
had parallel walls with septate and 45–90

branching. They
stained purple, and had a think, clear outer cell wall (Fig. 2).
The pleural effusion was consistent with eosinophilic to
mixed inflammation, consistent with a reaction to the dis-
seminated fungal disease. While waiting for culture results a
working diagnosis of aspergillosis was made and treatment
with itraconazole (5mg kg–1 PO q24h), amphotericin B
(1mg kg–1 IV CRI) and terbinafine (20mg kg–1 PO q12h)
was initiated. The patient presented again the following day
with an episode of bilateral epistaxis and worsening respira-
tory signs. Repeat radiographs showed moderate progres-
sion of pleural effusion and marked sublumbar
lymphadenopathy associated with moderate peritoneal
effusion, and hepatomegaly. The dog was persistently
pyrexic, so itraconazole and terbinafine were withdrawn
and treatment with voriconazole (5mg kg–1 PO q12h) was
commenced.
The patient was hospitalized and repeat abdominal ultra-
sound scans revealed new heterogeneous appearance of the
liver with numerous hypoechoic lesions. Cytology of the
hepatic lesions revealed marked pyogranulomatous inflam-
mation with fungal hyphae and inter-hepatocellular bile
casts, indicating cholestasis.
Microbiological examination of hepatic lesion fluid isolated
a pure growth of a fungus described as having macro- and
micro-morphological characteristics similar to those of Pur-
pureocillium species and Paecilomyces species; no Aspergillus
species was isolated. As the identity of the isolate was not
clear from colony morphology or microscopic examination,
molecular identification was used. An internal transcribed
spacer (ITS) region of the ribosomal DNA gene cluster was
amplified and sequenced on both strands with primers ITS-
F and ITS-R [1]. The resultant 422 bp ITS region sequence
was identified using the ISHAM-ITS database (http://its.
mycologylab.org) [2]. The highest match was 99.763%
nucleotide identity to the ITS region of the type strain of R.
piperina (CBS 408.73; NCBI accession no. NR_120176.1,
position 71–492). To confirm the identity as R. piperina,
fragments of the beta-tubulin and calmodulin genes were
amplified and sequenced on both strands using the
Fig. 1. Caudocranial and mediolateral projections of the left femur on initial presentation (a, c) and on second assessment (b, d) show-
ing disease progression. (a,c) Moderate, generalized and patchy increase in radiopacity within the medulla (star) and smooth, continu-
ous periosteal new bone formation along the medial cortex (arrow). (b,d) Large region of mixed lysis and proliferation affecting the
medulla of the proximal diaphysis (star) with associated marked lamellar periosteal reaction (arrow). Note moderate loss of muscle
mass visible on the caudocranial view (b) when compared to the first assessment (a).
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respective primer pairs Bt2a/Bt2b and Cmd5/Cmd6 as
described previously [3]. Both sequences showed 100%
nucleotide identity with the respective genes of R. piperina
CBS 408.73 (beta-tubulin JX273000.1, positions 45–439; and
calmodulin JX272936.1, positions 43–422). Antifungal sus-
ceptibility was performed using the YS07 Vitek card (bio-
Merieux), and MICs were as follows: fluconazole 32mg l–1,
voriconazole 4mg l 1, caspofungin 0.5mg l 1, micafungin
<0.006mg l 1, amphotericin <0.25mg l 1 and flucytosine
<1mg l 1.
OUTCOME AND FOLLOW-UP
Despite the ongoing treatment the dog continued to deterio-
rate: large volumes of pleural fluid were continually drained
and peripheral oedema developed. Due to the progressive
decline, the owners elected to have the dog euthanized.
DISCUSSION
Infections with the Rasamsonia species complex are an
emerging problem in human medicine, particularly in
immunocompromised patients [4–8]. To date there have
only been two previous case reports of Rasamsonia species
infection in veterinary medicine [9, 10]. Both cases were of
single German shepherd dogs infected with R. argillacea
[10] and R. piperina [9] (initially reported as Geosmithia
piperina [11]).
The main similarities in the two cases include age and breed.
Systemic aspergillosis has been most commonly reported in
German shepherd dogs between 2 and 8 years of age [12–
16] and it has been suggested that a hereditary immune
defect might exist [17–20] alongside mucosal immunity
dysfunction [21]. This heredity susceptibility may extend to
Rasamsonia species complex infection and highlights the
need to consider other fungal causes beyond Aspergillus spe-
cies for systemic mycoses in this breed.
Presenting signs in our case were similar to those of R. argil-
lacea [10] where an initial lameness was the primary com-
plaint. In the previous case report of R. piperina [9], the
main presenting signs were acute-onset glaucoma of the
right eye together with combined presence of lethargy, spi-
nal hyperpathia, panuveitis, haematuria and pyuria. None
of those were seen in our case, where the signs of systemic
disease were limited to pyrexia and, later in the disease
course, epistaxis and respiratory signs.
Both dogs in previous reports [9, 10] had radiographic signs
consistent with discosponydlitis. In the case described here
the initial radiographic findings were consistent with pan-
osteitis, and lesions characteristic of osteomyelitis did not
develop until later.
Neither of the previous veterinary Rasamsonia species
mycosis reported macroscopic pulmonary or pleural
involvement although that has been reported in human
medicine in patients with cystic fibrosis undergoing lung
transplants [4, 5, 8]. There were abnormalities on abdomi-
nal ultrasound of both previous dogs. The previously
reported case [9] had bilateral renal pelvic dilation with all
other organs appearing normal, unlike in our case where a
clear splenic, hepatic and lymphoid involvement was
present.
In the case described here the diagnosis of disseminated
fungal infection was reached following fine needle aspirates
from the spleen, lymph nodes and liver. Fungal hyphae
were also observed in the pleural effusion following thoraco-
centesis, unlike the previous veterinary reports [9, 10] where
the diagnosis was reached following aspirates or biopsies of
the vertebral bodies or sternebra. Molecular characterization
was pivotal in distinguishing the fungal species in all three
reports.
Recent antifungal testing [11] on Rasamsonia species
showed that caspofungin had significant activity in vitro,
followed by amphotericin B and posaconazole. In another
study voriconazole and isavuconazole had poor in vitro
activity against Rasamsonia isolates and the echoinocandins
were found to be the most effective agents [22]. Voricona-
zole was the least active of the antifungals tested [11, 22]
and amphotericin B was added only late in the course of the
disease, which may be the reason for the poor outcome in
this case.
It is possible that previous cases reported as Aspergillus or
Paecilomyces might have actually been Rasamsonia species
infections. We agree with other authors [10] and suggest
that molecular fungal identification is warranted in future
cases, which so far has only rarely been done in veterinary
publications. A study has successfully validated a commer-
cially available real-time PCR assay that reliably detected
three species from the R. argillacea complex direct from
clinical specimens and from culture isolates [23]. We believe
Fig. 2. Image from the abdominal mass: note the presence of high
numbers of macrophages associated with several fungal hyphae. A
few neutrophils are also present in the background. Romanowsky
staining, 400 magnification. Bar, 50 µm.
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that the Rasamsonia species complex is potentially an
underappreciated and misdiagnosed pathogen and that
molecular approaches should be used in suspect cases
because of the potentially aggressive disease pattern and
refractoriness to medical treatment [6, 9, 11, 24].
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